MedTrace Logo

A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

NCT04645810 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-10-15

No results posted yet for this study

Summary

The purpose of this study is to learn more about what effects the use of high-dose-rate (HDR) brachytherapy on prostate cancer recurrence, seen by AXUMIN PET scan, has on prostate cancer.

Conditions

Interventions

PROCEDURE

High-Dose-Rate Brachytherapy

High-Dose-Rate Brachytherapy Targeting only to AXUMIN PET Visible Lesion

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Hong Zhang · University of Rochester Wilmot Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-29
Primary Completion
2025-08-04
Completion
2025-08-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645810 on ClinicalTrials.gov